Log in or Sign up for Free to view tailored content for your specialty!
Cutaneous Oncology News
VIDEO: Updates to actinic keratosis treatment
WAILEA, Hawaii — The treatment of actinic keratosis can be challenging. At the Maui Derm meeting, George M. Martin, MD, meeting founder and program director, and Ted Rosen, MD, gave an update on treatment options.
Mohs surgery lessens recurrence, improves survival rates in head and neck melanoma
Mohs micrographic surgery decreased recurrence rates and increased survival among patients with head and neck melanoma compared with conventional excision, according to a study.
Log in or Sign up for Free to view tailored content for your specialty!
Deep tumor invasion, perineural invasion associated with poor prognosis in CSCC
Tumor invasion beyond the subcutaneous fat, along with perineural invasion, were associated with poor outcomes in primary cutaneous squamous cell carcinoma, according to a study.
Melanoma of unknown primary associated with similar survival as cutaneous primary
Despite more frequent poor prognostic factors, melanoma of unknown primary etiology was not associated with poorer survival than melanoma of known cutaneous etiology, according to a study.
Melanoma stage, tumor thickness impact survival rate in adolescents, young adults
Adolescents and young adults with stage IV melanoma experienced significantly lower survival rates compared with older adults, according to a study.
Melanoma survival rates high in children, adolescents
Melanoma survival rates in children and adolescent patients were around 90% or higher, according to a study.
Most read cutaneous oncology articles of 2022
Healio has compiled a top 10 list of its most read articles related to cutaneous oncology in 2022.
31-GEP testing should be considered in new melanoma patients
Dermatologists should consider ordering a 31-gene expression profile test to determine metastasis risk in patients with newly diagnosed cutaneous malignant melanoma, according to a study.
mRNA cancer vaccine combined with Keytruda promising in adjuvant treatment of melanoma
mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, with Keytruda met the primary endpoint of recurrence-free survival in a phase 2b trial for the adjuvant treatment of stage III/IV melanoma after surgical resection.
Tool shows continued efficacy in determining skin cancer risk among transplant recipients
A tool designed to assess skin cancer risk in solid organ transplant recipients proved to be efficacious in independent populations outside of the one used in its creation, according to a study.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read